Cedar Wealth Management’s AstraZeneca AZN Stock Holding History

Cedar Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-267	Closed	-$37.3K	–	246
2025 Q2	$37.3K	Hold	267	–	–	0.01%	126
2025 Q1	$39.2K	Hold	267	–	–	0.01%	120
2024 Q4	$35K	Hold	267	–	–	0.01%	115
2024 Q3	$41.6K	Hold	267	–	–	0.01%	160
2024 Q2	$41.6K	Sell	267 -58	-18%	-$8.73K	0.01%	167
2024 Q1	$44K	Buy	325 +58	+22%	+$7.68K	0.01%	174
2023 Q4	$36K	Hold	267	–	–	0.01%	171
2023 Q3	$36.2K	Hold	267	–	–	0.01%	173
2023 Q2	$38.2K	Hold	267	–	–	0.01%	173
2023 Q1	$37.1K	Hold	267	–	–	0.02%	174
2022 Q4	$36.2K	Hold	267	–	–	0.02%	164
2022 Q3	$29K	Hold	267	–	–	0.01%	195
2022 Q2	$35K	Hold	267	–	–	0.02%	188
2022 Q1	$35K	Hold	267	–	–	0.01%	207
2021 Q4	$31K	Buy	+267	New	+$31.4K	0.01%	214
2018 Q4	–	Sell	-58	Closed	-$5K	–	163
2018 Q3	$5K	Hold	58	–	–	﹤0.01%	141
2018 Q2	$4K	Buy	+58	New	+$4.17K	﹤0.01%	172
2017 Q4	–	Sell	-300	Closed	-$20K	–	129
2017 Q3	$20K	Hold	300	–	–	0.01%	102
2017 Q2	$20K	Hold	300	–	–	0.01%	101
2017 Q1	$19K	Hold	300	–	–	0.01%	98
2016 Q4	$16K	Hold	300	–	–	0.01%	100
2016 Q3	$20K	Hold	300	–	–	0.01%	83
2016 Q2	$18K	Hold	300	–	–	0.01%	93
2016 Q1	$17K	Buy	+300	New	+$18K	0.01%	81

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cedar Wealth Management's AZN Position: Q3 2025 in Review

Cedar Wealth Management sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 267 shares — an estimated $37.3K sold.

Cedar Wealth Management first reported a position in AZN in Q1 2016 and held it in 24 quarters. The position peaked at $44K in Q1 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

Cedar Wealth Management reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
Cedar Wealth Management sold 267 AstraZeneca shares in Q3 2025, an estimated $37.3K.
Cedar Wealth Management first reported a position in AstraZeneca in Q1 2016 and held it in 24 quarters.
Cedar Wealth Management's AstraZeneca position peaked at $44K in Q1 2024.
1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Cedar Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.